Drug development for airway diseases: looking forward

Stephen T. Holgate,Alvar Agusti,Robert M. Strieter,Gary P. Anderson,Robert Fogel,Elisabeth H. Bel,Thomas R. Martin,Theodore F. Reiss

Drug development for airway diseases: looking forward

2015

Stephen T. Holgate
Alvar Agusti
Robert M. Strieter
Gary P. Anderson
Robert Fogel
Elisabeth H. Bel
Thomas R. Martin
Theodore F. Reiss

Advancing drug development for airway diseases beyond the established mechanisms and symptomatic therapies requires redefining the classifications of airway diseases, considering systemic manifestations, developing new tools and encouraging collaborations.

Keywords:

Pharmacology
Airway
Drug development
Medicine
Drug discovery
Anti-asthmatic Agent
pulmonary disease
Intensive care medicine
Asthma
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations